脑膜炎球菌感染。2. 1969 - 1970年C群脑膜炎球菌多糖疫苗现场试验。
Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70.
作者信息
Gold R, Artenstein M S
出版信息
Bull World Health Organ. 1971;45(3):279-82.
Abstract
A second large-scale field trial of group C meningococcal polysaccharide vaccine in US Army recruits confirmed the efficacy and safety of the vaccine. When the results of all studies over a 2-year period were combined, the reduction in group-specific disease rates was 89.5%.
摘要
美国陆军新兵中进行的C群脑膜炎球菌多糖疫苗第二次大规模现场试验证实了该疫苗的有效性和安全性。当将两年期间所有研究的结果合并后，特定菌群疾病发病率的降低率为89.5%。
相似文献
1
Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70.脑膜炎球菌感染。2. 1969 - 1970年C群脑膜炎球菌多糖疫苗现场试验。
Bull World Health Organ. 1971;45(3):279-82.
2
Prevention of meningococcal disease by group C polysaccharide vaccine.C群多糖疫苗预防脑膜炎球菌病
N Engl J Med. 1970 Feb 19;282(8):417-20. doi: 10.1056/NEJM197002192820803.
3
Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.在大规模接种C群脑膜炎球菌多糖疫苗1年后加泰罗尼亚地区的脑膜炎球菌病情况
Infection. 2003 Dec;31(6):392-7. doi: 10.1007/s15010-003-3121-6.
4
Meningococcal carriage and vaccination in army recruits in Italy.意大利新兵中的脑膜炎球菌携带情况与疫苗接种
Boll Ist Sieroter Milan. 1990;69(1):357-9.
5
Control of meningococcal meningitis with meningococcal vaccines.用脑膜炎球菌疫苗控制脑膜炎球菌性脑膜炎
Yale J Biol Med. 1975 Jul;48(3):197-200.
6
Meningococcal infections. 3. Studies of group A polysaccharide vaccines.脑膜炎球菌感染。3. A群多糖疫苗的研究。
Bull World Health Organ. 1971;45(3):283-6.
7
Meningococcal infections. 1. Prevalence of serogroups causing disease in US Army personnel in 1964-70.脑膜炎球菌感染。1. 1964年至1970年美国陆军人员中引起疾病的血清群患病率。
Bull World Health Organ. 1971;45(3):275-8.
8
9
10
Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.既往多糖疫苗接种对成人C群脑膜炎球菌破伤风类毒素结合疫苗免疫反应的强度、持续时间、质量及安全性的影响
Clin Diagn Lab Immunol. 2004 Nov;11(6):1100-4. doi: 10.1128/CDLI.11.6.1100-1104.2004.
引用本文的文献
1
Herd Protection against Meningococcal Disease through Vaccination.通过疫苗接种实现群体对脑膜炎球菌病的保护。
Microorganisms. 2020 Oct 28;8(11):1675. doi: 10.3390/microorganisms8111675.
2
Impact of Vaccines; Health, Economic and Social Perspectives.疫苗的影响；健康、经济和社会视角。
Front Microbiol. 2020 Jul 14;11:1526. doi: 10.3389/fmicb.2020.01526. eCollection 2020.
3
Standing on the shoulders of giants: two centuries of struggle against meningococcal disease.站在巨人的肩膀上：两个世纪以来对抗脑膜炎球菌病的斗争。
Lancet Infect Dis. 2019 Aug;19(8):e284-e294. doi: 10.1016/S1473-3099(19)30040-4. Epub 2019 Apr 30.
4
Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development.迈向全球控制脑膜炎奈瑟菌的进展：21 世纪的疫苗、当前指南以及未来疫苗开发的挑战。
Hum Vaccin Immunother. 2018 May 4;14(5):1146-1160. doi: 10.1080/21645515.2018.1451810. Epub 2018 May 9.
5
Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field.建立疫苗研发的保护相关性：呼吸道合胞病毒疫苗领域的考量
Viral Immunol. 2018 Mar;31(2):195-203. doi: 10.1089/vim.2017.0147. Epub 2018 Jan 16.
6
How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines.脑膜炎奈瑟菌与人免疫系统相互作用的知识如何被用于制备有效的脑膜炎球菌疫苗。
J Immunol Res. 2015;2015:189153. doi: 10.1155/2015/189153. Epub 2015 Aug 17.
7
Global practices of meningococcal vaccine use and impact on invasive disease.全球脑膜炎球菌疫苗的使用情况及其对侵袭性疾病的影响。
Pathog Glob Health. 2014 Jan;108(1):11-20. doi: 10.1179/2047773214Y.0000000126.
8
Will there ever be a universal Staphylococcus aureus vaccine?会有通用的金黄色葡萄球菌疫苗吗？
Hum Vaccin Immunother. 2013 Sep;9(9):1865-76. doi: 10.4161/hv.25182. Epub 2013 Jun 21.
9
Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.因子 H 结合蛋白在脑膜炎奈瑟菌毒力中的作用及其作为广泛预防脑膜炎球菌病疫苗候选物的潜力。
Microbiol Mol Biol Rev. 2013 Jun;77(2):234-52. doi: 10.1128/MMBR.00056-12.
10
Meningococcal disease serogroup C.脑膜炎奈瑟菌 C 群
Risk Manag Healthc Policy. 2012;5:1-15. doi: 10.2147/RMHP.S12711. Epub 2012 Mar 8.
本文引用的文献
1
Serological typing of meningococci by means of micro-precipitation.通过微量沉淀法对脑膜炎球菌进行血清学分型。
Antonie Van Leeuwenhoek. 1961;27:305-15. doi: 10.1007/BF02538460.
2
Meningococcal infections. 1. Prevalence of serogroups causing disease in US Army personnel in 1964-70.脑膜炎球菌感染。1. 1964年至1970年美国陆军人员中引起疾病的血清群患病率。
Bull World Health Organ. 1971;45(3):275-8.
3
Evaluation of group C meningococcal polysaccharide vaccine in marine recruits, San Diego, California.加利福尼亚州圣地亚哥海军新兵中C群脑膜炎球菌多糖疫苗的评估
Am J Epidemiol. 1970 Jul;92(1):25-32. doi: 10.1093/oxfordjournals.aje.a121176.
4
Cutaneous reactions and antibody response to meningococcal group C polysaccharide vaccines in man.人对C群脑膜炎球菌多糖疫苗的皮肤反应及抗体应答
J Infect Dis. 1970 Apr;121(4):372-7. doi: 10.1093/infdis/121.4.372.
5
Prevention of meningococcal disease by group C polysaccharide vaccine.C群多糖疫苗预防脑膜炎球菌病
N Engl J Med. 1970 Feb 19;282(8):417-20. doi: 10.1056/NEJM197002192820803.
6
Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state.人类对脑膜炎球菌的免疫力。五、用C群脑膜炎球菌多糖免疫对带菌状态的影响。
J Exp Med. 1969 Jun 1;129(6):1385-95. doi: 10.1084/jem.129.6.1385.
7
Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.人类对脑膜炎球菌的免疫力。IV. A群和C群脑膜炎球菌多糖对人类志愿者的免疫原性。
J Exp Med. 1969 Jun 1;129(6):1367-84. doi: 10.1084/jem.129.6.1367.
8
Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.人类对脑膜炎球菌的免疫力。3. A 群、B 群和 C 群脑膜炎球菌多糖的制备及免疫化学性质。
J Exp Med. 1969 Jun 1;129(6):1349-65. doi: 10.1084/jem.129.6.1349.
9
Prevalence of meningococcal serogroups and description of three new groups.脑膜炎球菌血清群的流行情况及三个新血清群的描述
Am J Epidemiol. 1968 May;87(3):643-6. doi: 10.1093/oxfordjournals.aje.a120854.
10
Respiratory disease and the adenoviruses.呼吸系统疾病与腺病毒
Med Clin North Am. 1967 May;51(3):769-79. doi: 10.1016/s0025-7125(16)33045-0.
Zotero 插件